Comprehensive Epilepsy Center Clinical Trials
NYU Langone’s Comprehensive Epilepsy Center has been participating in clinical drug trials sponsored by various pharmaceutical companies for more than 14 years. Participation in a clinical trial offers patients the possibility of access to new antiepileptic medications before they come to market. Our clinicians are committed to conducting clinical research that benefits both adults and children who have epilepsy or seizure disorders.
Led by Jacqueline A. French, MD, clinical trials director, and Blanca Vazquez, MD, and Claude Steriade, MD, CM, clinical trials co-directors, patients at the Comprehensive Epilepsy Center have taken part in more than 100 multicenter protocols for treating both focal and generalized epilepsy.
Patients are screened for eligibility according to each trial’s criteria by their physicians, along with research coordinators, including Stephanie Tenzigolski, RN, Tobi Clement, LaToya King, Patricia Tolete, and Alice Yu, RN. Once enrolled in a clinical trial, participants receive regular evaluation by the research staff to assess the safety and efficacy of the drug or treatment under study.
If you have uncontrolled seizures, are between the ages of 12 and 80, and are interested in participating in a clinical trial, please speak to your doctor or contact us at 646-558-0842 to determine your eligibility for any of our ongoing trials.